ImmuneSpec

ImmuneSpec

Foundation date

27/01/2023

Sector

#Biotechnology / R&D Services

Subsector

• #R&D Services - Bioinformatics
• #R&D Services - CRO (Contract Research Organization)
• #R&D Services - Proteomics
• #R&D Services - Screening

Therapeutic areas

• #Diseases of the blood and blood-forming organs - immune disorders
• #Neoplasms / cancer / oncology
• #Symptoms - signs and abnormal clinical and laboratory findings - not elsewhere classified

ImmuneSpec offers MHC associated peptide proteomics (MAPPS) as a service. We developed an advanced immunopeptidomics platform which allows fast & reliable identification of immunogenic peptides to pinpoint all peptide regions which evoke an immune response. Key applications include pinpointing immunogenic areas for the development of broad-spectrum vaccines, identification of neo-antigens for the generation of leads suitable for immunotherapy, and testing of biologics for unwanted immunogenicity.